Takeda Italia announces the appointment of Chiara Giorgi as Strategy and Operations Head. One of the main objectives of the division headed by Giorgi is to contribute to the implementation of a new organizational model in line with corporate strategies and the needs of a constantly changing market. With this task Giorgi will work transversally with all areas of the company, guiding Takeda’s process of innovation and digital acceleration, through the development of the five core capabilities that Takeda has identified as crucial for being closer to patients, caregivers and healthcare professionals: Omnichannel Engagement, which will allow to reach the different stakeholders through a combination of digital and traditional tools, Insight Analytics, to improve decision-making processes based on data integration Press Release 2, New Products Planning, essential to guide in a way effective the launches of new products, Evidence Generations Management, to generate evidence on the management of care pathways and therapies in real life and consolidate the data package to support the value of the drugs developed by Takeda, Value-Based Partnership, to continue building valuable partnerships with the National Health System and with Regions: In line with the strategy and mission of the Group at a global level, the function led by Giorgi will also have the task of developing sustainability initiatives, to be implemented through both internal and external activities, with the support of Takeda’s field force. . “The ultimate goal is to increase, on the one hand, the awareness and knowledge of the organization on environmental sustainability and, on the other hand, to minimize the impact of corporate activities on our planet, to help preserve it – explains one note from Takeda Italia-. In this context of internal development, Chiara Giorgi’s experience in managing heterogeneous work groups will be decisive “.” A great challenge awaits me – commented Giorgi – to allow Takeda Italia to make a further leap in quality. ” company has affirmed its leadership role in various therapeutic areas, in Italy and globally, but we want to continue working to develop increasingly innovative and effective processes and tools, at the service of our first objective: to improve the lives of I will therefore work to facilitate the research and application of even more efficient solutions and processes, which favor agility, innovation and the development of solutions for the benefit of patients and their carers. objectives there is also the dissemination of the principles and tools of Lean Management within the Company, a work management system that Takeda has been promoting for some time to improve the the ability of care, through the optimization of processes and systems. We aim for excellence “. With a degree in Pharmaceutical Chemistry and Technology from the La Sapienza University of Rome and many years of experience in leading international pharmaceutical companies, such as Janssen, Msd, Abbott and Abbvie, a reality in which Giorgi has held various roles in Operations area of the establishment, local and international medical and marketing in multiple therapeutic areas, in 2015 she joined Takeda Italy with the role of Marketing Lead of the Gastroenterology BU, successfully guiding the launch and management strategies of the innovative drug portfolio of the business unit. “Takeda is ready to strengthen the role of strategic partner of the country, to build together with institutions and stakeholders a growing heritage for health, economy, society and the environment. And, to achieve this ambitious result – commented Annarita Egidi, CEO by Takeda Italia – I believe that Chiara Giorgi is the right person, with her experience, passion and energy already, she will guide us to constantly pursue the excellence and growth of our organization “. Takeda is a leading global biopharmaceutical company that works with healthcare professionals, patient organizations and institutions to enable access to innovative medicines that truly make a difference in patients’ lives. Takeda is present in over 80 countries and is present in the areas: oncology, gastroenterology, neuroscience, rare diseases, with targeted investments in the field of plasma-derived medicines and vaccines.